BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 11751427)

  • 1. UV-induced DNA incision and proliferating cell nuclear antigen recruitment to repair sites occur independently of p53-replication protein A interaction in p53 wild type and mutant ovarian carcinoma cells.
    Riva F; Zuco V; Vink AA; Supino R; Prosperi E
    Carcinogenesis; 2001 Dec; 22(12):1971-8. PubMed ID: 11751427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of apoptosis and stress response in ovarian carcinoma cell lines treated with ST1926, an atypical retinoid.
    Zuco V; Zanchi C; Cassinelli G; Lanzi C; Supino R; Pisano C; Zanier R; Giordano V; Garattini E; Zunino F
    Cell Death Differ; 2004 Mar; 11(3):280-9. PubMed ID: 14657960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for loss of p53 function in sensitivity of ovarian carcinoma cells to taxanes.
    Cassinelli G; Supino R; Perego P; Polizzi D; Lanzi C; Pratesi G; Zunino F
    Int J Cancer; 2001 Jun; 92(5):738-47. PubMed ID: 11340581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cells deficient in p53 regulated p21(waf1/cip1) expression exhibit normal nucleotide excision repair of UV-induced DNA damage.
    Wani MA; Wani G; Yao J; Zhu Q; Wani AA
    Carcinogenesis; 2002 Mar; 23(3):403-10. PubMed ID: 11895854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of p53 mutant cisplatin-resistant ovarian carcinoma cells following drug exposure: spontaneously mutant selection.
    Righetti SC; Perego P; Corna E; Pierotti MA; Zunino F
    Cell Growth Differ; 1999 Jul; 10(7):473-8. PubMed ID: 10437915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor p53 dependent recruitment of nucleotide excision repair factors XPC and TFIIH to DNA damage.
    Wang QE; Zhu Q; Wani MA; Wani G; Chen J; Wani AA
    DNA Repair (Amst); 2003 May; 2(5):483-99. PubMed ID: 12713809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms and implications of the age-associated decrease in DNA repair capacity.
    Goukassian D; Gad F; Yaar M; Eller MS; Nehal US; Gilchrest BA
    FASEB J; 2000 Jul; 14(10):1325-34. PubMed ID: 10877825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential binding kinetics of replication protein A during replication and the pre- and post-incision steps of nucleotide excision repair.
    Gourdin AM; van Cuijk L; Tresini M; Luijsterburg MS; Nigg AL; Giglia-Mari G; Houtsmuller AB; Vermeulen W; Marteijn JA
    DNA Repair (Amst); 2014 Dec; 24():46-56. PubMed ID: 25453469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase-immortalized human fibroblasts retain UV-induced mutagenesis and p53-mediated DNA damage responses.
    Porter PC; Clark DR; McDaniel LD; McGregor WG; States JC
    DNA Repair (Amst); 2006 Jan; 5(1):61-70. PubMed ID: 16140041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p21(waf1/cip1)-null human fibroblasts are deficient in nucleotide excision repair downstream the recruitment of PCNA to DNA repair sites.
    Stivala LA; Riva F; Cazzalini O; Savio M; Prosperi E
    Oncogene; 2001 Feb; 20(5):563-70. PubMed ID: 11313988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of correlation between DNA strand breakage and p53 protein levels in human fibroblast strains exposed to ultraviolet lights.
    Enns L; Murray D; Mirzayans R
    Photochem Photobiol; 2000 Oct; 72(4):562-8. PubMed ID: 11045730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient PCNA complex formation is dependent upon both transcription coupled repair and genome overall repair.
    Balajee AS; May A; Dianova I; Bohr VA
    Mutat Res; 1998 Dec; 409(3):135-46. PubMed ID: 9875289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts.
    Ford JM; Hanawalt PC
    J Biol Chem; 1997 Oct; 272(44):28073-80. PubMed ID: 9346961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53-degradation by HPV-16 E6 preferentially affects the removal of cyclobutane pyrimidine dimers from non-transcribed strand and sensitizes mammary epithelial cells to UV-irradiation.
    El-Mahdy MA; Hamada FM; Wani MA; Zhu Q; Wani AA
    Mutat Res; 2000 Mar; 459(2):135-45. PubMed ID: 10725664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of p21CDKN1A after DNA damage is independent of type of lesion, and is not required for DNA repair.
    Savio M; Coppa T; Cazzalini O; Perucca P; Necchi D; Nardo T; Stivala LA; Prosperi E
    DNA Repair (Amst); 2009 Jul; 8(7):778-85. PubMed ID: 19321391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian cancer cisplatin-resistant cell lines: multiple changes including collateral sensitivity to Taxol.
    Perego P; Romanelli S; Carenini N; Magnani I; Leone R; Bonetti A; Paolicchi A; Zunino F
    Ann Oncol; 1998 Apr; 9(4):423-30. PubMed ID: 9636834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between replication protein A and p53 is disrupted after UV damage in a DNA repair-dependent manner.
    Abramova NA; Russell J; Botchan M; Li R
    Proc Natl Acad Sci U S A; 1997 Jul; 94(14):7186-91. PubMed ID: 9207066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the TP53 gene affected recruitment of 53BP1 protein to DNA lesions, but level of 53BP1 was stable after γ-irradiation that depleted MDC1 protein in specific TP53 mutants.
    Suchánková J; Legartová S; Ručková E; Vojtěšek B; Kozubek S; Bártová E
    Histochem Cell Biol; 2017 Sep; 148(3):239-255. PubMed ID: 28397142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis as a determinant of tumor sensitivity to topotecan in human ovarian tumors: preclinical in vitro/in vivo studies.
    Caserini C; Pratesi G; Tortoreto M; Bedogné B; Carenini N; Supino R; Perego P; Righetti SC; Zunino F
    Clin Cancer Res; 1997 Jun; 3(6):955-61. PubMed ID: 9815771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.